Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LYRA | NRXP | ENLV | ||
| Company | Lyra Therapeutics Inc | Nrx Pharmaceuticals Inc | Enlivex Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4400 | 3.06 | 1.5700 | ||
| High | 0.4900 | 3.22 | 1.6274 | ||
| Low | 0.4100 | 2.74 | 1.5400 | ||
| Last | 0.4200 | 2.81 | 1.5800 | ||
| Change | -0.1015 | -0.25 | +0.0100 | ||
| % Change | -19.46% | -8.17% | +0.64% | ||
| Volume | 18,458,609 | 1,056,838 | 43,403 | ||
| 20-Day Average Volume | 6,691,361 | 833,161 | 360,860 | ||
| Previous Close | 0.5215 | 3.06 | 1.5700 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.6460 | 3.49 | 1.6325 | ||
| 20-Day Raw Stochastic | 1.35% | 22.20% | 14.14% | ||
| 20-Day Relative Strength | 17.09% | 41.84% | 36.87% | ||
| Weighted Alpha | -22.00 | -30.26 | -41.71 | ||
| Today's Opinion | 24% Sell | 40% Sell | 40% Sell | ||
| Previous Opinion | 24% Sell | 40% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -91.86% since 04/30/24 | +8.91% since 04/30/24 | -5.39% since 04/30/24 | ||
| Low | 0.3600 on 05/06/24 | 1.90 on 05/02/24 | 1.5110 on 05/01/24 | ||
| High | 5.6500 on 05/01/24 | 3.75 on 05/06/24 | 1.7600 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -91.63% since 04/05/24 | -46.98% since 04/05/24 | -60.50% since 04/05/24 | ||
| Low | 0.3600 on 05/06/24 | 1.90 on 05/02/24 | 1.1500 on 04/15/24 | ||
| High | 5.7700 on 04/17/24 | 6.00 on 04/12/24 | 4.2100 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -91.43% since 02/07/24 | -30.84% since 02/07/24 | -40.60% since 02/07/24 | ||
| Low | 0.3600 on 05/06/24 | 1.90 on 05/02/24 | 1.1500 on 04/15/24 | ||
| High | 6.7900 on 03/27/24 | 7.33 on 03/05/24 | 4.5900 on 04/03/24 | ||
| 6-Month | |||||
| %Chg | -85.67% since 11/07/23 | -21.29% since 11/07/23 | -18.97% since 11/07/23 | ||
| Low | 0.3600 on 05/06/24 | 1.90 on 05/02/24 | 1.1500 on 04/15/24 | ||
| High | 6.7900 on 03/27/24 | 7.33 on 03/05/24 | 4.5900 on 04/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,793 | 32,298 | 29,200 | ||
| Shares Outstanding, K | 60,965 | 10,555 | 18,599 | ||
| Annual Sales | 1,560,000 | 0 | 0 | ||
| Annual Net Income | -62,680,000 | -30,150,000 | -29,070,000 | ||
| Last Quarter Sales | 530,000 | 0 | 0 | ||
| Last Quarter Net Income | -22,450,000 | -4,330,000 | -9,100,000 | ||
| 60-Month Beta | 0.31 | 1.15 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 04/30/24 | -0.50 on 03/29/24 | -0.48 on 03/29/24 | ||
| Latest Earnings Date | 05/10/24 | 05/21/24 | 06/21/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||